Prolactin, cortisol, and antidepressant treatment
In four depressed patients with abnormal dexamethasone suppression test results before treatment, plasma prolactin levels significantly increased after successful amitriptyline therapy. Such an increase did not take place in five depressed patients with normal dexamethasone suppression test findings...
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 1988-03, Vol.145 (3), p.358-360 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 360 |
---|---|
container_issue | 3 |
container_start_page | 358 |
container_title | The American journal of psychiatry |
container_volume | 145 |
creator | FAVA, G. A LISANSKY, J BUCKMAN, M. T KELLNER, R PATHAK, D FAVA, M PEAKE, G. T |
description | In four depressed patients with abnormal dexamethasone suppression test
results before treatment, plasma prolactin levels significantly increased
after successful amitriptyline therapy. Such an increase did not take place
in five depressed patients with normal dexamethasone suppression test
findings. |
doi_str_mv | 10.1176/ajp.145.3.358 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78110745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1775839</sourcerecordid><originalsourceid>FETCH-LOGICAL-a407t-55cc10ee7df819f3175beadade848073452f18f689a403c671e13ac9c15081443</originalsourceid><addsrcrecordid>eNp10EtLAzEQB_AgSq3Vo0ehqHiQ7prJe49SfEFBDwreQprNwpZ9mewe_PamdBERPYQkzI-Z4Y_QKeAUQIobs-lSYDylKeVqD02BU55IQtQ-mmKMSZJx-n6IjkLYxC-mkkzQhFLGFCdTBC--rYzty2Yxt63vy9BWi7lp8nj6MneddyHE57z3zvS1a_pjdFCYKriT8Z6ht_u71-Vjsnp-eFrerhLDsOwTzq0F7JzMCwVZQUHytTO5yZ1iCkvKOClAFUJl0VMrJDigxmYWOFbAGJ2hq13fzrcfgwu9rstgXVWZxrVD0FIBYMl4hOe_4KYdfBN304RgJjIht-jiPwQUsMCCkiyqZKesb0PwrtCdL2vjPzVgvU1bx7R1TFtTHdOO_mzsOqxrl3_rMd5YvxzrJlhTFd40tgzfTEqRMb5d7nrHTNeVPxb7c-YX19WSTw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310606329</pqid></control><display><type>article</type><title>Prolactin, cortisol, and antidepressant treatment</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>FAVA, G. A ; LISANSKY, J ; BUCKMAN, M. T ; KELLNER, R ; PATHAK, D ; FAVA, M ; PEAKE, G. T</creator><creatorcontrib>FAVA, G. A ; LISANSKY, J ; BUCKMAN, M. T ; KELLNER, R ; PATHAK, D ; FAVA, M ; PEAKE, G. T</creatorcontrib><description>In four depressed patients with abnormal dexamethasone suppression test
results before treatment, plasma prolactin levels significantly increased
after successful amitriptyline therapy. Such an increase did not take place
in five depressed patients with normal dexamethasone suppression test
findings.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.145.3.358</identifier><identifier>PMID: 3344852</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Washington, DC: American Psychiatric Publishing</publisher><subject>Adult ; Amitriptyline - therapeutic use ; Biological and medical sciences ; Depressive Disorder - diagnosis ; Depressive Disorder - drug therapy ; Depressive Disorder - psychology ; Dexamethasone ; Female ; Hospitalization ; Humans ; Hydrocortisone - blood ; Male ; Medical research ; Medical sciences ; Mental depression ; Middle Aged ; Neuropharmacology ; Pharmacology. Drug treatments ; Prolactin - blood ; Psychiatry ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology</subject><ispartof>The American journal of psychiatry, 1988-03, Vol.145 (3), p.358-360</ispartof><rights>1988 INIST-CNRS</rights><rights>Copyright American Psychiatric Association Mar 1988</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a407t-55cc10ee7df819f3175beadade848073452f18f689a403c671e13ac9c15081443</citedby><cites>FETCH-LOGICAL-a407t-55cc10ee7df819f3175beadade848073452f18f689a403c671e13ac9c15081443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.145.3.358$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.145.3.358$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2846,21608,27846,27901,27902,77533,77534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7769455$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3344852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FAVA, G. A</creatorcontrib><creatorcontrib>LISANSKY, J</creatorcontrib><creatorcontrib>BUCKMAN, M. T</creatorcontrib><creatorcontrib>KELLNER, R</creatorcontrib><creatorcontrib>PATHAK, D</creatorcontrib><creatorcontrib>FAVA, M</creatorcontrib><creatorcontrib>PEAKE, G. T</creatorcontrib><title>Prolactin, cortisol, and antidepressant treatment</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>In four depressed patients with abnormal dexamethasone suppression test
results before treatment, plasma prolactin levels significantly increased
after successful amitriptyline therapy. Such an increase did not take place
in five depressed patients with normal dexamethasone suppression test
findings.</description><subject>Adult</subject><subject>Amitriptyline - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - drug therapy</subject><subject>Depressive Disorder - psychology</subject><subject>Dexamethasone</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hydrocortisone - blood</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Mental depression</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prolactin - blood</subject><subject>Psychiatry</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNp10EtLAzEQB_AgSq3Vo0ehqHiQ7prJe49SfEFBDwreQprNwpZ9mewe_PamdBERPYQkzI-Z4Y_QKeAUQIobs-lSYDylKeVqD02BU55IQtQ-mmKMSZJx-n6IjkLYxC-mkkzQhFLGFCdTBC--rYzty2Yxt63vy9BWi7lp8nj6MneddyHE57z3zvS1a_pjdFCYKriT8Z6ht_u71-Vjsnp-eFrerhLDsOwTzq0F7JzMCwVZQUHytTO5yZ1iCkvKOClAFUJl0VMrJDigxmYWOFbAGJ2hq13fzrcfgwu9rstgXVWZxrVD0FIBYMl4hOe_4KYdfBN304RgJjIht-jiPwQUsMCCkiyqZKesb0PwrtCdL2vjPzVgvU1bx7R1TFtTHdOO_mzsOqxrl3_rMd5YvxzrJlhTFd40tgzfTEqRMb5d7nrHTNeVPxb7c-YX19WSTw</recordid><startdate>19880301</startdate><enddate>19880301</enddate><creator>FAVA, G. A</creator><creator>LISANSKY, J</creator><creator>BUCKMAN, M. T</creator><creator>KELLNER, R</creator><creator>PATHAK, D</creator><creator>FAVA, M</creator><creator>PEAKE, G. T</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19880301</creationdate><title>Prolactin, cortisol, and antidepressant treatment</title><author>FAVA, G. A ; LISANSKY, J ; BUCKMAN, M. T ; KELLNER, R ; PATHAK, D ; FAVA, M ; PEAKE, G. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a407t-55cc10ee7df819f3175beadade848073452f18f689a403c671e13ac9c15081443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Amitriptyline - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - drug therapy</topic><topic>Depressive Disorder - psychology</topic><topic>Dexamethasone</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hydrocortisone - blood</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Mental depression</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prolactin - blood</topic><topic>Psychiatry</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FAVA, G. A</creatorcontrib><creatorcontrib>LISANSKY, J</creatorcontrib><creatorcontrib>BUCKMAN, M. T</creatorcontrib><creatorcontrib>KELLNER, R</creatorcontrib><creatorcontrib>PATHAK, D</creatorcontrib><creatorcontrib>FAVA, M</creatorcontrib><creatorcontrib>PEAKE, G. T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FAVA, G. A</au><au>LISANSKY, J</au><au>BUCKMAN, M. T</au><au>KELLNER, R</au><au>PATHAK, D</au><au>FAVA, M</au><au>PEAKE, G. T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolactin, cortisol, and antidepressant treatment</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1988-03-01</date><risdate>1988</risdate><volume>145</volume><issue>3</issue><spage>358</spage><epage>360</epage><pages>358-360</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>In four depressed patients with abnormal dexamethasone suppression test
results before treatment, plasma prolactin levels significantly increased
after successful amitriptyline therapy. Such an increase did not take place
in five depressed patients with normal dexamethasone suppression test
findings.</abstract><cop>Washington, DC</cop><pub>American Psychiatric Publishing</pub><pmid>3344852</pmid><doi>10.1176/ajp.145.3.358</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-953X |
ispartof | The American journal of psychiatry, 1988-03, Vol.145 (3), p.358-360 |
issn | 0002-953X 1535-7228 |
language | eng |
recordid | cdi_proquest_miscellaneous_78110745 |
source | MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
subjects | Adult Amitriptyline - therapeutic use Biological and medical sciences Depressive Disorder - diagnosis Depressive Disorder - drug therapy Depressive Disorder - psychology Dexamethasone Female Hospitalization Humans Hydrocortisone - blood Male Medical research Medical sciences Mental depression Middle Aged Neuropharmacology Pharmacology. Drug treatments Prolactin - blood Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology |
title | Prolactin, cortisol, and antidepressant treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T07%3A26%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolactin,%20cortisol,%20and%20antidepressant%20treatment&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=FAVA,%20G.%20A&rft.date=1988-03-01&rft.volume=145&rft.issue=3&rft.spage=358&rft.epage=360&rft.pages=358-360&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/ajp.145.3.358&rft_dat=%3Cproquest_cross%3E1775839%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310606329&rft_id=info:pmid/3344852&rfr_iscdi=true |